Your Partner for Regulatory Affairs, Quality Compliance, Clinical Research & Certification Support Across China & APAC

Cisema delivers expert clinical development, regulatory, and market access services to help companies bring their products to market faster and stay compliant across Asia Pacific. Whether pharmaceuticals, medical devices, cosmetics, health foods, toys, machinery, or electronic components, we support your success from development to approval and beyond.

With deep experience in China and a growing presence across the region, we provide local insight with global perspective, enabling innovation, ensuring regulatory compliance, and accelerating your growth in target markets.

20+ years of experience
100+ team members
Offices in 10 markets
1,000+ customers worldwide
Your Partner for Regulatory and Market Access
Your Partner for Clinical Development
Professional headshot of Stefan Fischer, Founder and Managing Director at Cisema, a person with short light-brown hair and glasses wearing a navy suit, white shirt, and red tie, standing in a softly lit modern office corridor with a blurred background—corporate leadership portrait associated with regulatory compliance consulting, product registration, and market access support for China and the Asia-Pacific region.

Our Story

Cisema was founded in 2002 by Stefan Fischer, who first worked in Beijing with Siemens in the 1990s. When China joined the World Trade Organisation (WTO) in 2001, Stefan recognized a clear need: companies wanting to access the Chinese market needed a trusted partner who understood both regulatory requirements and cross-cultural dynamics.

Cisema was created to meet that need.

Today, we are a trusted provider of market access services for companies entering China and the wider Asia Pacific region. From startups to multinational leaders, we guide clients through regulatory strategy, product registration, independent testing, and post-market compliance with precision and care.

Our offices span China’s industrial hubs and strategic locations in the APAC region. We combine on-the-ground knowledge with international quality standards, delivering bilingual support that bridges regulatory gaps and drives faster time to market.

We remain proudly family-owned and focused on building long-term relationships. With leadership experience in China dating back to 1985, we offer unmatched depth of regulatory intelligence, cultural fluency, and expertise.

Whether launching a new product, expanding your regional footprint, or ensuring compliance, Cisema’s market access services provide the clarity and confidence you need to succeed in global markets.

Cisema’s Growth Timeline

Cisema has been at the forefront of enabling market access and market entry for over two decades, supporting pharmaceutical companies, medical device manufacturers, and innovators across diverse industries. Our growth timeline is a testament to our commitment to helping clients navigate complex regulatory requirements and achieve market access. From our early days assisting with specialized equipment licensing to becoming trusted market access specialists for new markets, we have consistently delivered expert guidance and innovative solutions tailored to our clients’ needs.

1990s
2002
2004
2009
2015
2019
2025

1990s – The Spark

Stefan Fischer, a German national and former Siemens engineer, moves to Beijing and experiences China’s regulatory evolution firsthand.

2002 – Cisema is Founded

Co-founded in Germany and Beijing, Cisema begins with services focused on China Compulsory Certification for automotive and machinery.

2004 – Medical Device & IVD Registration Services

With the introduction of China’s medical device regulatory requirements, Cisema expands its remit to assist medical device and IVD manufacturers with product licenses and GMP compliance.

2009 – Sourcing & Quality Control Expansion

China strengthens pharmaceutical licensing regulations. In response, Cisema broadens its operations to support combination products and strategy consulting in pharma and biotech.

2015 – Service Diversification

To complement existing services and meet client demand, Cisema extends support to:
• Cosmetics and new cosmetic ingredients
• Health foods and dietary supplements
• Veterinary products
These extensions align with our commitment to providing full-spectrum market access and regulatory compliance across industries.

2019 – Pharma & Biotech Expansion

China strengthens pharmaceutical licensing regulations. In response, Cisema broadens its operations to support combination products, DMF submissions, and strategy consulting in pharma and biotech.

2025 – Geographic Expansion

Cisema launches market access services in Taiwan, Malaysia, Singapore, Thailand, Vietnam, the Philippines, and Indonesia. This milestone reflects our growth into a wider APAC market access provider, helping companies enter new markets, reduce costs, and ensure safety across borders.

Meet Some of Our Team

Hamish King

CEO

Stefan Fischer

Founder & Managing Director Hong Kong SAR

Sunny Cao

General Manager, Hangzhou

Nick Guo

General Manager: Beijing

Tan Shouzheng

VP Southeast Asia

Chelsea Wang

Group Controller

Florian Waegele

General Manager, Germany

Qiang Zhou

General Manager, Qingdao

Our Approach

At Cisema, our approach is comprehensive and data-driven, designed to deliver actionable insights and measurable value for our clients.

We combine real-world evidence and regulatory expertise to develop tailored strategies that support every stage of market entry and product lifecycle management. Our team works closely with clients to assess their unique needs, ensuring that each solution is aligned with business objectives and regulatory requirements.

Local Focus

While global market access is essential for business expansion, achieving success in each country requires a deep understanding of local regulatory requirements, market conditions, and patient or client needs. Cisema’s team leverages local expertise and strong in-country partnerships to develop tailored strategies that address the unique challenges and opportunities of each market.

We work closely with clients to ensure that their products meet all local regulatory standards, supporting seamless market entry and ongoing compliance. By combining our global perspective with local knowledge, we help clients navigate regulatory complexities, deliver value to customers and consumers and drive sustainable growth in every market they enter.

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

Our Locations

Head Office

Cisema (Hong Kong) Limited

7/A Shun Pont Commercial Building
5-11 Thomson Road, Wan Chai
Hong Kong

Other Locations

Asia-Pacific: Beijing | Hangzhou | Tianjin | Qingdao | Singapore | Penang | Tokyo | Seoul | Bangkok | Ho Chi Minh City | Manila | Jakarta | Taipei

Europe: Munich

North America: Chicago

Our Global Network

Cisema connects global companies with China and Asia Pacific through a network of international offices. Our headquarters in Hong Kong serves as the central hub for our APAC operations and a primary point of contact for companies entering or expanding across the region. Our additional offices across the region strengthen our presence in key markets and provide direct access to local regulatory authorities, test laboratories, and industry partners.

Our multilingual teams in offices worldwide work across time zones to ensure efficient communication and responsive service. Through clear coordination, transparent timelines, and careful budget management, we aim to process client requests within 24/48 hours and keep projects progressing smoothly.

In China, our offices in Hangzhou, Beijing, Tianjin and Qingdao are strategically located to support efficient regulatory and testing processes. The Beijing office leads certification and regulatory coordination, while the Hangzhou office focuses on sourcing and supply chain support in collaboration with other branches. The Tianjin office is located near leading NMPA-certified test centers, enabling efficient coordination of local testing and compliance activities.

Together, this network connects Cisema directly to China’s major economic regions, including the Yangtze River Delta, the Pearl River Delta, and the Bohai Bay area, allowing us to maintain close communication with authorities, respond quickly to regulatory developments, and provide flexible operational support for our clients.

We also have increasing presence throughout other markets, including Malaysia, Singapore, Vietnam, Indonesia, the Philippines, Thailand, Taiwan and South Korea. These enable us to serve our clients throughout East Asia and the ASEAN economies and act as local authorised representative so that manufacturers don't need to set up their own offices or rely on distributors, who are focused on sales targets rather than obtaining approvals, complying with regulations (to keep the sales won) and guarding intellectual property. 

Our long-standing relationships with regulatory authorities and accredited laboratories enhance efficiency and help anticipate regulatory developments. This proactive approach enables us to keep clients and industry partners informed and prepared for changes across China and the wider Asia Pacific region.

Across all offices, secure digital infrastructure and modern IT systems ensure that project data remains protected while allowing seamless collaboration between our teams and clients worldwide.

Latest Insights

View More

Digital Medical Device Clinical Trials in South Korea: Understanding the MFDS Framework

Understand MFDS clinical trial requirements for digital medical devices, including real-world evidence, data-based studies, and software validation expectations.

June 2, 2026
Digital Medical Device Clinical Trials in South Korea: Understanding the MFDS Framework

Cisema Expands into South Korea

Supporting foreign manufacturers entering South Korea with regulatory services for medical devices, IVDs, and quasi-drugs.

June 1, 2026
Cisema Expands into South Korea
Seoul skyline in the early evening

Indonesia Halal Certification for Health Supplements: What Manufacturers & Importers Need to Know

Understand Indonesia halal certification requirements for health supplements, including BPJPH registration, ingredient review, and halal labeling obligations.

May 20, 2026
Indonesia Halal Certification for Health Supplements: What Manufacturers & Importers Need to Know
A person dressed in a flowing black hijab holds a small red capsule delicately between their fingers, presenting it toward the camera. Their expressive eyes are sharply focused forward, while the softly blurred background.

Indonesia Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Learn which products are covered by Indonesia's halal framework, the labeling and manufacturing obligations, and phased compliance timelines.

May 20, 2026
Indonesia Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know
A healthcare worker in a white coat checks a seated patient’s blood pressure while another medical staff member in green scrubs stands nearby holding a clipboard in a bright clinic setting.

Understanding Indonesia Halal Cosmetic Certification Requirements

Learn how Indonesia halal cosmetic certification works, including BPJPH requirements, halal labeling rules, ingredient compliance, and registration obligations.

May 20, 2026
Understanding Indonesia Halal Cosmetic Certification Requirements

Medical Device Market Access for Thailand, Indonesia, and the Philippines

Cisema offers regulatory insight and market access strategy for medical devices in Thailand, Indonesia, and the Philippines.

May 15, 2026
Medical Device Market Access for Thailand, Indonesia, and the Philippines
Medical Device Market Access for Thailand, Indonesia, and the Philippines
Previous
Previous

Contact Our Experts & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal